Proscar for hair loss is an increasingly discussed option for men seeking to manage male pattern baldness, though its use in this context is off-label in the UK. Proscar contains finasteride 5 mg, a medicine originally licensed for benign prostatic hyperplasia. The clinically established and licensed dose for androgenetic alopecia is finasteride 1 mg (Propecia). Understanding how Proscar works, how it differs from licensed alternatives, and what safety considerations apply is essential before starting treatment. This article covers the mechanism of action, dosage guidance, side effects, and when to seek professional advice.

How Proscar Works to Treat Hair Loss

Proscar (finasteride 5 mg) reduces DHT by approximately 60–70% by inhibiting 5-alpha reductase, slowing hair follicle miniaturisation at the crown and mid-scalp; results typically emerge after 3–6 months of consistent use.

Proscar is a brand name for finasteride 5 mg, a medicine originally licensed in the UK for the treatment of benign prostatic hyperplasia (enlarged prostate). It is also used off-label for male pattern hair loss (androgenetic alopecia), a condition driven largely by the hormone dihydrotestosterone (DHT). A lower-dose formulation — finasteride 1 mg, sold as Propecia — holds a specific UK licence for male pattern hair loss in men aged 18 to 41 years. Proscar is sometimes considered as a cost-saving alternative, but its use for hair loss is off-label and carries important practical and safety considerations (see dosage section below).

Not sure if this is normal? Chat with one of our pharmacists →

Finasteride works by inhibiting the enzyme 5-alpha reductase, which converts testosterone into DHT. DHT binds to receptors in hair follicles, causing them to miniaturise progressively — a process that leads to thinning and eventual hair loss. By reducing circulating DHT levels by approximately 60–70%, finasteride helps to slow this miniaturisation and, in many men, encourages partial regrowth of hair in affected areas. Response is most evident at the vertex (crown) and mid-scalp; regrowth at the frontal hairline is less predictable and less likely.

Finasteride does not cure androgenetic alopecia; it manages the underlying hormonal driver. Initial improvement is typically seen after 3 to 6 months of consistent use, with maximal benefit reached at around 12 months. Continuing treatment beyond 12 months helps to maintain the response. If treatment is stopped, the hair loss process generally resumes within 6 to 12 months.

Finasteride is not effective for hair loss caused by other conditions, such as alopecia areata or telogen effluvium, and is not licensed for use in women, particularly those who are or may become pregnant, due to the risk of harm to a male foetus. Further information is available from the NHS hair loss pages, the electronic Medicines Compendium (eMC) SmPCs for Propecia 1 mg and Proscar 5 mg, and NICE Clinical Knowledge Summaries (CKS) on hair loss.

Recommended Dosage and How to Take Proscar

The licensed dose for male pattern hair loss is finasteride 1 mg once daily (Propecia); Proscar 5 mg is an off-label alternative, and tablet splitting is imprecise and must only be done under direct medical supervision.

When finasteride is used for male pattern hair loss, the clinically established and licensed dose is 1 mg once daily, as reflected in Propecia 1 mg. Where clinically appropriate, a prescriber may consider Proscar 5 mg as an off-label, cost-saving option; however, the licensed 1 mg product is preferred wherever possible.

If a clinician does direct the use of Proscar for hair loss, some practitioners suggest splitting the tablet into quarters to approximate a 1 mg to 1.25 mg dose. This approach carries important limitations: Proscar tablets are film-coated and not scored, meaning splitting is imprecise, compromises the film coating, and cannot guarantee dose uniformity. Tablet splitting should only be undertaken under direct medical supervision, using a tablet cutter, and with clear handling precautions in place. Women who are or may become pregnant must not handle crushed or broken finasteride tablets, as absorption through the skin poses a risk of harm to a male foetus. Intact, film-coated tablets present minimal handling risk, but broken or crushed tablets must be stored safely and kept out of reach of children.

Finasteride should be taken once daily, with or without food, at roughly the same time each day. There is no clinical benefit to taking doses above 1 mg for hair loss — higher doses do not produce superior results and increase the risk of side effects.

Experiencing these side effects? Our pharmacists can help you navigate them →

Key practical points:

• Consistency is essential — missing doses regularly may reduce effectiveness

• Results take time — initial changes are typically noticed after 3–6 months; full benefit by around 12 months

• If a dose is missed, do not double up; simply continue with the next scheduled dose

• Blood donation — do not donate blood during treatment or for at least one month after the last dose, to prevent finasteride being given to a pregnant woman via transfusion

• Storage — keep at room temperature, away from moisture and direct sunlight

Any prescription for Proscar or finasteride for hair loss should come from a qualified healthcare professional who has assessed your suitability, medical history, and potential contraindications. Refer to the BNF finasteride monograph and the relevant eMC SmPCs for full prescribing detail.

Possible Side Effects and Safety Considerations

Finasteride can cause sexual dysfunction, depression, and suicidal thoughts; the MHRA has issued safety communications and a patient alert card, and side effects should be reported via the Yellow Card Scheme.

Finasteride is generally well tolerated, but like all medicines it carries a risk of side effects. The most clinically significant adverse effects relate to sexual function and mental health, and both are included in the UK Summary of Product Characteristics (SmPC) and MHRA Drug Safety Updates.

Sexual side effects reported include:

• Decreased libido (reduced sex drive)

• Erectile dysfunction

• Ejaculatory disorders, including reduced semen volume

• Gynaecomastia (breast tissue enlargement or tenderness)

These effects occur in a minority of users and typically resolve on stopping treatment. However, there are reports of persistent sexual dysfunction in some individuals even after discontinuation — sometimes referred to as Post-Finasteride Syndrome (PFS). The MHRA has acknowledged these reports, and the condition remains an area of ongoing research.

Psychiatric effects: The UK SmPC and MHRA safety communications confirm that finasteride has been associated with depression and suicidal thoughts. If you experience low mood, depression, or any thoughts of self-harm whilst taking finasteride, stop the medicine and seek medical advice promptly. The MHRA has issued a patient alert card for finasteride, which prescribers and pharmacists should provide; ask your clinician or pharmacist if you have not received one.

Other important risks include:

• Male breast changes — rare cases of male breast cancer have been reported. Seek prompt medical review if you notice a breast lump, breast pain, or nipple discharge

• Testicular pain — reported in post-marketing experience

• Male infertility and reduced semen quality — rare reports exist; these often improve after stopping treatment

• Hypersensitivity reactions — including rash, urticaria, and angioedema (swelling of the face, lips, tongue, or throat); seek urgent medical attention if these occur

PSA (prostate-specific antigen) testing: Finasteride reduces PSA levels by approximately 50% after six or more months of use. If you are having a PSA test or prostate assessment, always inform your doctor or nurse that you are taking finasteride. Clinicians may adjust the interpretation of PSA results accordingly — for example, by doubling the measured value — to account for this effect. Any rise in PSA whilst on finasteride should be investigated. A baseline PSA measurement before starting treatment may be appropriate in some men.

Contraindications: Finasteride is contraindicated in women and children. Men with liver disease should use it with caution, as finasteride is metabolised hepatically.

Always disclose all current medicines to your prescriber to check for interactions. Report any suspected side effects via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or via the Yellow Card app. Further safety information is available in the eMC SmPCs for Propecia 1 mg and Proscar 5 mg, and in MHRA Drug Safety Updates on finasteride.

Talking to Your GP or a Specialist About Hair Loss Treatment

Speak to a GP before starting finasteride to confirm the diagnosis, rule out underlying causes, and determine whether Propecia or referral to a dermatologist is appropriate.

If you are considering Proscar or finasteride for hair loss, the first and most important step is to speak with a qualified healthcare professional. Hair loss can have multiple causes — including thyroid disorders, iron deficiency anaemia, scalp conditions, and psychological stress — and it is essential to establish the correct diagnosis before starting any treatment. Your GP can carry out a clinical assessment and, where appropriate, arrange blood tests to rule out underlying medical causes.

NICE Clinical Knowledge Summaries (CKS) and NHS guidance recommend a structured approach to hair loss, which may include lifestyle advice, topical treatments such as minoxidil, and referral to a dermatologist for more complex or uncertain cases. Finasteride is one option within this landscape, but it is not suitable for everyone. Your GP will consider your:

• Age and overall health — finasteride 1 mg (Propecia) is licensed for men aged 18 to 41 years

• Medical history, including any history of prostate conditions, liver disease, or mood disorders

• Current medicines that may interact with finasteride

• Personal preferences and expectations regarding treatment outcomes

Because Proscar is not licensed for hair loss, many GPs will prefer to prescribe Propecia (finasteride 1 mg) if they determine finasteride is appropriate. Finasteride for male pattern hair loss may not be routinely available on the NHS and may require a private prescription depending on local prescribing policies; your GP can advise on this.

Referral to a consultant dermatologist is appropriate for complex, rapidly progressive, or diagnostically uncertain cases. Trichologists can provide specialist advice on hair and scalp health, but they are not medically regulated and cannot prescribe medicines; diagnosis and prescribing should be undertaken by a GP or dermatologist. Private hair loss clinics and regulated online prescribing services are available in the UK — ensure any service is registered with the Care Quality Commission (CQC), that any pharmacy is registered with the General Pharmaceutical Council (GPhC), and that prescribers are registered with the General Medical Council (GMC).

Seek prompt medical advice if you experience any of the following, as they may indicate a condition requiring separate investigation:

• Sudden or rapidly progressive hair loss

• Patchy hair loss

• Scalp pain, inflammation, or scaling

• Hair loss accompanied by systemic symptoms such as fatigue, weight changes, or skin changes

• Breast changes such as a lump, pain, or nipple discharge

• Low mood, depression, or thoughts of self-harm

Useful UK resources include the NHS hair loss pages, NICE CKS on hair loss, and the British Association of Dermatologists patient information on male pattern hair loss.

Frequently Asked Questions